tiprankstipranks
Trending News
More News >
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
US Market

Vaxcyte (PCVX) Income Statement

Compare
459 Followers

Vaxcyte Income Statement

Last quarter (Q4 2025), Vaxcyte's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Vaxcyte's net income was $-246.51M. See Vaxcyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 923.67M$ 569.55M$ 468.04M$ 232.26M$ 103.67M
Depreciation and Amortization
$ 24.86M$ 15.85M$ 10.17M$ 9.45M$ 3.46M
EBITDA
$ -741.77M$ -448.08M$ -392.10M$ -214.03M$ -96.61M
Operating Income
$ -923.67M$ -569.55M$ -468.04M$ -232.26M$ -103.67M
Other Income/Expenses
$ 157.05M$ 105.62M$ 65.78M$ 8.77M$ 3.59M
Pretax Income
$ -766.63M$ -463.93M$ -402.27M$ -223.49M$ -100.08M
Net Income
$ -766.63M$ -463.93M$ -402.27M$ -223.49M$ -100.08M
Per Share Metrics
Basic EPS
$ -5.63$ -3.80$ -4.14$ -3.44$ -1.93
Diluted EPS
$ -5.63$ -3.80$ -4.14$ -3.44$ -1.93
Weighted Average Shares Outstanding
136.09M 122.00M 97.16M 64.88M 51.92M
Weighted Average Shares Outstanding (Diluted)
136.09M 122.00M 97.16M 64.88M 51.92M
Currency in USD

Vaxcyte Earnings and Revenue History